Progress in Pathogen Defense, Dr. Carolyn Myers Discusses FendX's Collaboration with Dunmore
Channel: InvestorCoffee
Date: 13/11/2023

In a recent interview with InvestorNews host Tracy Weslosky, FendX Technologies Inc.’s (CSE: FNDX | OTCQB: FDXTF) President, CEO, and Director Dr. Carolyn Myers discussed their recently announced agreement with Dunmore International for a second pilot run of FendX’s REPELWRAP™ film. REPELWRAP™ is an award-winning protective surface coating film that prevents the adhesion of pathogens and reduces their transmission on surfaces prone to contamination.

This collaboration follows a successful first pilot run where FendX's REPELWRAP™ film was validated for automated commercial production. Dr. Myers elaborated that the second pilot run is poised to refine formulation processes, paving the way for commercial production anticipated early next year.

Beyond the REPELWRAP™ film, FendX is actively engaged in diversified projects such as spray nanotechnology and coated catheters, underscoring their commitment to make people’s lives safer. With a Master Services Agreement signed with nanoComposix for scale-up development of FendX’s spray nanotechnology, Dr. Myers discussed how coating medical catheters with FendX’s nanotechnology can prevent bacterial biofilm formation and blockage.

About FendX Technologies Inc.

FendX is a Canada-based nanotechnology company focused on developing products to make people’s lives safer by reducing the spread of pathogens. The Company is developing both film and spray products to protect surfaces from contamination. The lead product under development, REPELWRAP™ film, is a protective surface coating film that, due to its repelling properties, prevents the adhesion of pathogens and reduces their transmission on surfaces prone to contamination. The spray nanotechnology is a bifunctional spray coating being developed to reduce contamination on surfaces by repelling and killing pathogens. The Company is conducting research and development activities using its nanotechnology in collaboration with industry-leading partners, including McMaster University. The Company has an exclusive worldwide license to its technology and IP portfolio from McMaster, which encompass both film and spray coating nanotechnology formulations.

Disclaimer: FendX Technologies Inc. is an advertorial member of InvestorNews Inc.

#nanotechnology #diseasecontrol #PathogenDefense